MyMD Pharmaceuticals (MYMD) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free MYMD Stock Alerts $2.50 +0.25 (+11.11%) (As of 04/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MyMD Pharmaceuticals Short Interest DataCurrent Short Volume109,100 sharesPrevious Short Volume93,400 sharesChange Vs. Previous Month+16.81%Dollar Volume Sold Short$260,749.00Short Interest Ratio / Days to Cover0.5Last Record DateMarch 31, 2024Outstanding Shares2,160,000 sharesFloat Size1,900,000 sharesShort Percent of Float5.74%Today's Trading Volume54,000 sharesAverage Trading Volume614,283 sharesToday's Volume Vs. Average9% Short Selling MyMD Pharmaceuticals ? Sign up to receive the latest short interest report for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMYMD Short Interest Over TimeMYMD Days to Cover Over TimeMYMD Percentage of Float Shorted Over Time Ad AltimetryI’m officially sounding the alarm.AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.Just click here to watch my full uncensored interview. MyMD Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024109,100 shares $260,749.00 +16.8%5.7%0.5 $2.39 3/15/202493,400 shares $268,992.00 +0.8%5.1%1.7 $2.88 2/29/202492,700 shares $317,961.00 -5.4%5.2%1.6 $3.43 2/15/202498,000 shares $320,460.00 -95.9%5.5%1.7 $3.27 1/31/20242,400,000 shares $360,000.00 -32.4%5.5%1.6 $0.15 1/15/20243,550,000 shares $699,350.00 +3.2%8.2%2.5 $0.20 Get the Latest News and Ratings for MYMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20233,440,000 shares $889,928.00 +8.2%7.9%2.8 $0.26 12/15/20233,180,000 shares $731,400.00 -19.5%7.3%3.7 $0.23 11/30/20233,950,000 shares $1.11 million +17.9%9.3%5.4 $0.28 11/15/20233,350,000 shares $1.17 million +2.1%7.9%5.1 $0.35 10/31/20233,280,000 shares $1.39 million -9.6%8.7%5.4 $0.43 10/15/20233,630,000 shares $1.53 million +4.0%9.7%4.5 $0.42 9/30/20233,490,000 shares $2.07 million +19.1%9.3%4.1 $0.59 9/15/20232,930,000 shares $1.80 million -0.7%7.8%3.8 $0.61 8/31/20232,950,000 shares $2.81 million +7.7%8.0%4.1 $0.95 8/15/20232,740,000 shares $3.49 million -32.0%7.4%3.8 $1.28 7/31/20234,030,000 shares $5.84 million +13.8%12.0%5.6 $1.45 7/15/20233,540,000 shares $2.83 million -1.7%10.6%6.7 $0.80 6/30/20233,600,000 shares $5.40 million -2.7%10.7%7.4 $1.50 6/15/20233,700,000 shares $6.07 million +3.9%11.3%7.5 $1.64 5/31/20233,560,000 shares $6.19 million +11.3%10.9%6.5 $1.74 5/15/20233,200,000 shares $6.11 million -0.6%9.8%6.1 $1.91 4/30/20233,220,000 shares $5.83 million +6.3%9.9%6.4 $1.81 4/15/20233,030,000 shares $4.67 million +2.0%9.3%6 $1.54 3/31/20232,970,000 shares $5.11 million +44.2%9.1%6.4 $1.72 3/15/20232,060,000 shares $3.63 million +48.2%6.4%5.3 $1.76 2/28/20231,390,000 shares $2.65 million +47.8%4.3%4.6 $1.91 2/15/2023940,500 shares $2.17 million +18.7%2.9%3.7 $2.31 1/31/2023792,200 shares $2.14 million +9.8%2.4%3.4 $2.70 1/15/2023721,600 shares $1.10 million -1.1%2.2%4.4 $1.52 12/30/2022729,900 shares $839,385.00 -14.8%2.3%4.6 $1.15 12/15/2022856,600 shares $1.16 million -5.1%2.6%5.1 $1.35 11/30/2022902,400 shares $1.93 million +25.8%2.8%5.2 $2.14 11/15/2022717,200 shares $1.43 million +3.4%2.2%4.2 $1.99 10/31/2022693,800 shares $1.92 million +1.5%2.1%3.2 $2.77 10/15/2022683,400 shares $1.58 million +1.6%2.1%2.8 $2.31 9/30/2022672,900 shares $1.76 million +5.4%2.1%2.4 $2.61 9/15/2022638,700 shares $2.22 million -6.4%2.0%2.1 $3.48 8/31/2022682,600 shares $2.55 million -2.4%2.0%2.5 $3.74 8/15/2022699,200 shares $3.02 million +24.8%2.0%2.7 $4.32I’m officially sounding the alarm. (Ad)AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.Just click here to watch my full uncensored interview. MYMD Short Interest - Frequently Asked Questions What is MyMD Pharmaceuticals' current short interest? Short interest is the volume of MyMD Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 109,100 shares of MYMD short. 5.74% of MyMD Pharmaceuticals' shares are currently sold short. Learn More on MyMD Pharmaceuticals' current short interest. Which institutional investors are shorting MyMD Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MyMD Pharmaceuticals: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for MyMD Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.74% of MyMD Pharmaceuticals' floating shares are currently sold short. Is MyMD Pharmaceuticals' short interest increasing or decreasing? MyMD Pharmaceuticals saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 109,100 shares, an increase of 16.8% from the previous total of 93,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MyMD Pharmaceuticals' float size? MyMD Pharmaceuticals currently has issued a total of 2,160,000 shares. Some of MyMD Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MyMD Pharmaceuticals currently has a public float of 1,900,000 shares. How does MyMD Pharmaceuticals' short interest compare to its competitors? 5.74% of MyMD Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MyMD Pharmaceuticals: Biomerica, Inc. (0.40%), Trinity Biotech plc (0.02%), Leafly Holdings, Inc. (1.15%), Lipella Pharmaceuticals Inc. (1.24%), Shineco, Inc. (0.09%), BIOLASE, Inc. (7.46%), Artelo Biosciences, Inc. (0.45%), Genprex, Inc. (3.78%), Processa Pharmaceuticals, Inc. (1.56%), ZyVersa Therapeutics, Inc. (8.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short MyMD Pharmaceuticals stock? Short selling MYMD is an investing strategy that aims to generate trading profit from MyMD Pharmaceuticals as its price is falling. MYMD shares are trading up $0.25 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MyMD Pharmaceuticals? A short squeeze for MyMD Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYMD, which in turn drives the price of the stock up even further. How often is MyMD Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYMD, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: BMRA Short Squeeze TRIB Short Squeeze LFLY Short Squeeze LIPO Short Squeeze SISI Short Squeeze BIOL Short Squeeze ARTL Short Squeeze GNPX Short Squeeze PCSA Short Squeeze ZVSA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYMD) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceYour Money is Not SafeAmerican Alternative